Sotera Health Company (SHC) Stock Forecast, Price Target & Predictions
SHC Stock Forecast
Sotera Health Company stock forecast is as follows: an average price target of $17.43 (represents a 25.58% upside from SHC’s last price of $13.88) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.
SHC Price Target
The average price target for Sotera Health Company (SHC) is $17.43 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $25.00 to $8.00. This represents a potential 25.58% upside from SHC's last price of $13.88.
SHC Analyst Ratings
According to 12 Wall Street analysts, Sotera Health Company's rating consensus is 'Buy'. The analyst rating breakdown for SHC stock is 0 'Strong Buy' (0.00%), 6 'Buy' (50.00%), 5 'Hold' (41.67%), 1 'Sell' (8.33%), and 0 'Strong Sell' (0.00%).
Sotera Health Company Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 06, 2024 | David Windley | Jefferies | $18.00 | $15.27 | 17.88% | 29.68% |
| Aug 06, 2024 | Luke Sergott | Barclays | $17.00 | $14.22 | 19.55% | 22.48% |
| Jun 06, 2024 | David Windley | Jefferies | $14.50 | $11.98 | 21.04% | 4.47% |
| May 21, 2024 | Jason Bednar | Piper Sandler | $13.00 | $10.91 | 19.16% | -6.34% |
| May 03, 2024 | Sean Dodge | RBC Capital | $17.00 | $10.91 | 55.82% | 22.48% |
| Apr 10, 2024 | Luke Sergott | Barclays | $14.00 | $11.62 | 20.48% | 0.86% |
| Mar 25, 2024 | David Windley | Jefferies | $15.50 | $11.94 | 29.87% | 11.67% |
| Jun 26, 2023 | Matthew Mishan | Loop Capital Markets | $24.00 | $18.59 | 29.14% | 72.91% |
| Jan 10, 2023 | Mike Polark | Wolfe Research | $25.00 | $17.25 | 44.93% | 80.12% |
| Jan 10, 2023 | Luke Sergott | Barclays | $22.00 | $17.25 | 27.54% | 58.50% |
The latest Sotera Health Company stock forecast, released on Nov 06, 2024 by David Windley from Jefferies, set a price target of $18.00, which represents a 17.88% increase from the stock price at the time of the forecast ($15.27), and a 29.68% increase from SHC last price ($13.88).
Sotera Health Company Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 7 |
| Avg Price Target | $18.00 | $18.00 | $15.57 |
| Last Closing Price | $13.88 | $13.88 | $13.88 |
| Upside/Downside | 29.68% | 29.68% | 12.18% |
In the current month, the average price target of Sotera Health Company stock is $18.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 29.68% increase as opposed to Sotera Health Company's last price of $13.88. This month's average price target is down 0.00% compared to last quarter, and up 15.61% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 05, 2024 | Citigroup | Buy | Buy | Hold |
| Aug 06, 2024 | Barclays | Overweight | Overweight | Hold |
| Aug 05, 2024 | KeyBanc | Sector Weight | Sector Weight | Hold |
| Jun 06, 2024 | Jefferies | Buy | Buy | Hold |
| May 21, 2024 | RBC Capital | Buy | Buy | Hold |
| May 21, 2024 | Piper Sandler | - | Neutral | Initialise |
| May 03, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Apr 03, 2024 | RBC Capital | Buy | Buy | Hold |
| Apr 03, 2024 | Jefferies | Underperform | Underperform | Hold |
| Apr 03, 2024 | Citigroup | Neutral | Buy | Upgrade |
Sotera Health Company's last stock rating was published by Citigroup on Nov 05, 2024. The company gave SHC a "Buy" rating, the same as its previous rate.
Sotera Health Company Financial Forecast
Sotera Health Company Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $310.24M | $263.18M | $255.28M | $220.59M | $251.59M | $248.70M | $266.64M | $236.75M | $241.25M | $226.16M | $251.92M | $212.15M | $216.84M |
| Avg Forecast | $337.40M | $318.90M | $309.12M | $276.77M | $313.54M | $297.08M | $292.42M | $261.63M | $293.43M | $278.64M | $266.45M | $244.38M | $302.17M | $264.55M | $258.93M | $221.03M | $247.46M | $248.20M | $256.30M | $230.17M | $236.37M | $221.61M | $227.24M | $207.38M | $209.12M |
| High Forecast | $343.92M | $325.06M | $315.10M | $282.12M | $319.60M | $302.82M | $298.07M | $267.52M | $296.33M | $278.82M | $266.45M | $244.38M | $303.65M | $264.55M | $263.93M | $225.30M | $252.24M | $248.20M | $256.30M | $230.17M | $236.37M | $221.61M | $227.24M | $207.38M | $209.12M |
| Low Forecast | $332.33M | $314.11M | $304.48M | $272.61M | $308.83M | $292.62M | $288.02M | $256.83M | $291.02M | $278.46M | $266.45M | $244.38M | $300.70M | $264.55M | $255.03M | $217.70M | $243.74M | $248.20M | $256.30M | $230.17M | $236.37M | $221.61M | $227.24M | $207.38M | $209.12M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 0.99% | 0.99% | 1.00% | 1.02% | 1.00% | 1.04% | 1.03% | 1.02% | 1.02% | 1.11% | 1.02% | 1.04% |
Sotera Health Company's average Quarter revenue forecast for Mar 24 based on 2 analysts is $244.38M, with a low forecast of $244.38M, and a high forecast of $244.38M. SHC's average Quarter revenue forecast represents a -21.23% decrease compared to the company's last Quarter revenue of $310.24M (Dec 23).
Sotera Health Company EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $104.02M | $76.10M | $81.78M | $50.85M | $78.02M | $101.01M | $107.95M | $92.51M | $74.34M | $96.88M | $118.41M | $72.80M | $49.15M |
| Avg Forecast | $115.00M | $108.70M | $105.36M | $94.34M | $106.87M | $101.26M | $99.67M | $89.18M | $100.01M | $94.97M | $90.82M | $83.30M | $103.00M | $90.17M | $88.26M | $75.34M | $84.35M | $96.61M | $99.76M | $81.53M | $92.00M | $86.26M | $88.45M | $63.70M | $81.40M |
| High Forecast | $117.23M | $110.80M | $107.40M | $96.16M | $108.94M | $103.22M | $101.60M | $91.18M | $101.01M | $95.03M | $90.82M | $83.30M | $103.50M | $90.17M | $89.96M | $76.79M | $85.98M | $96.61M | $99.76M | $97.83M | $92.00M | $86.26M | $88.45M | $76.44M | $81.40M |
| Low Forecast | $113.27M | $107.06M | $103.78M | $92.92M | $105.26M | $99.74M | $98.17M | $87.54M | $99.19M | $94.91M | $90.82M | $83.30M | $102.50M | $90.17M | $86.93M | $74.20M | $83.08M | $96.61M | $99.76M | $65.22M | $92.00M | $86.26M | $88.45M | $50.96M | $81.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 0.84% | 0.93% | 0.67% | 0.92% | 1.05% | 1.08% | 1.13% | 0.81% | 1.12% | 1.34% | 1.14% | 0.60% |
2 analysts predict SHC's average Quarter EBITDA for Mar 24 to be $83.30M, with a high of $83.30M and a low of $83.30M. This is -19.93% lower than Sotera Health Company's previous annual EBITDA (Dec 23) of $104.02M.
Sotera Health Company Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $38.68M | $-13.66M | $23.51M | $2.84M | $-319.72M | $25.09M | $30.42M | $30.64M | $36.00M | $27.44M | $42.60M | $10.84M | $-43.68M |
| Avg Forecast | $80.65M | $69.54M | $66.76M | $48.37M | $70.82M | $62.98M | $57.78M | $40.03M | $60.72M | $52.20M | $47.03M | $35.47M | $73.60M | $56.52M | $52.24M | $38.85M | $62.56M | $63.79M | $68.87M | $27.24M | $63.02M | $57.97M | $59.19M | $9.49M | $21.37M |
| High Forecast | $82.68M | $71.29M | $68.43M | $49.58M | $72.60M | $64.56M | $59.23M | $42.89M | $63.62M | $52.32M | $47.07M | $35.50M | $79.27M | $56.53M | $53.55M | $39.82M | $64.13M | $63.79M | $68.87M | $32.68M | $63.02M | $57.97M | $59.19M | $11.38M | $21.37M |
| Low Forecast | $79.08M | $68.18M | $65.45M | $47.42M | $69.43M | $61.75M | $56.65M | $39.25M | $59.53M | $52.09M | $46.98M | $35.44M | $70.77M | $56.51M | $51.22M | $38.09M | $61.34M | $63.79M | $68.87M | $21.79M | $63.02M | $57.97M | $59.19M | $7.59M | $21.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.53% | -0.24% | 0.45% | 0.07% | -5.11% | 0.39% | 0.44% | 1.13% | 0.57% | 0.47% | 0.72% | 1.14% | -2.04% |
Sotera Health Company's average Quarter net income forecast for Mar 24 is $35.47M, with a range of $35.44M to $35.50M. SHC's average Quarter net income forecast represents a -8.29% decrease compared to the company's last Quarter net income of $38.68M (Dec 23).
Sotera Health Company SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $60.36M | $54.11M | $60.29M | $61.91M | $65.95M | $57.09M | $63.13M | $59.54M | $51.83M | $44.04M | $49.83M | $52.47M | $68.20M |
| Avg Forecast | $68.65M | $64.88M | $62.89M | $56.31M | $63.79M | $60.44M | $59.50M | $53.23M | $59.70M | $56.69M | $54.21M | $49.72M | $61.48M | $53.82M | $52.68M | $44.97M | $50.35M | $50.37M | $52.02M | $52.93M | $47.97M | $44.98M | $46.12M | $45.91M | $42.44M |
| High Forecast | $69.97M | $66.14M | $64.11M | $57.40M | $65.02M | $61.61M | $60.64M | $54.43M | $60.29M | $56.73M | $54.21M | $49.72M | $61.78M | $53.82M | $53.70M | $45.84M | $51.32M | $50.37M | $52.02M | $63.51M | $47.97M | $44.98M | $46.12M | $55.09M | $42.44M |
| Low Forecast | $67.61M | $63.91M | $61.95M | $55.46M | $62.83M | $59.54M | $58.60M | $52.25M | $59.21M | $56.66M | $54.21M | $49.72M | $61.18M | $53.82M | $51.89M | $44.29M | $49.59M | $50.37M | $52.02M | $42.34M | $47.97M | $44.98M | $46.12M | $36.73M | $42.44M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 1.01% | 1.14% | 1.38% | 1.31% | 1.13% | 1.21% | 1.13% | 1.08% | 0.98% | 1.08% | 1.14% | 1.61% |
Sotera Health Company's average Quarter SG&A projection for Mar 24 is $49.72M, based on 2 Wall Street analysts, with a range of $49.72M to $49.72M. The forecast indicates a -17.62% fall compared to SHC last annual SG&A of $60.36M (Dec 23).
Sotera Health Company EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.14 | $-0.05 | $0.08 | $0.01 | $-1.14 | $0.09 | $0.11 | $0.11 | $0.13 | $0.10 | $0.15 | $0.04 | $-0.17 |
| Avg Forecast | $0.28 | $0.24 | $0.23 | $0.17 | $0.25 | $0.22 | $0.20 | $0.14 | $0.21 | $0.18 | $0.16 | $0.12 | $0.26 | $0.20 | $0.18 | $0.14 | $0.22 | $0.22 | $0.24 | $0.19 | $0.22 | $0.20 | $0.21 | $0.16 | $0.08 |
| High Forecast | $0.29 | $0.25 | $0.24 | $0.17 | $0.25 | $0.23 | $0.21 | $0.15 | $0.22 | $0.18 | $0.16 | $0.12 | $0.28 | $0.20 | $0.19 | $0.14 | $0.22 | $0.22 | $0.24 | $0.19 | $0.22 | $0.20 | $0.21 | $0.16 | $0.08 |
| Low Forecast | $0.28 | $0.24 | $0.23 | $0.17 | $0.24 | $0.22 | $0.20 | $0.14 | $0.21 | $0.18 | $0.16 | $0.12 | $0.25 | $0.20 | $0.18 | $0.13 | $0.21 | $0.22 | $0.24 | $0.19 | $0.22 | $0.20 | $0.21 | $0.16 | $0.08 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.54% | -0.25% | 0.44% | 0.07% | -5.20% | 0.40% | 0.45% | 0.57% | 0.59% | 0.49% | 0.72% | 0.25% | -2.26% |
According to 2 Wall Street analysts, Sotera Health Company's projected average Quarter EPS for Mar 24 is $0.12, with a low estimate of $0.12 and a high estimate of $0.12. This represents a -11.27% decrease compared to SHC previous annual EPS of $0.14 (Dec 23).
Sotera Health Company Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | $3.14 | $14.00 | 345.86% | Buy |
| GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
| MYGN | Myriad Genetics | $15.22 | $29.00 | 90.54% | Hold |
| XGN | Exagen | $3.00 | $5.00 | 66.67% | Buy |
| ICLR | ICON Public Limited Company | $187.22 | $309.60 | 65.37% | Buy |
| IQV | IQVIA | $191.04 | $266.65 | 39.58% | Buy |
| MEDP | Medpace | $308.93 | $399.20 | 29.22% | Hold |
| QGEN | Qiagen | $40.99 | $51.89 | 26.59% | Buy |
| SHC | Sotera Health Company | $13.88 | $17.43 | 25.58% | Buy |
| NEOG | Neogen | $15.20 | $17.50 | 15.13% | Buy |
| RDNT | RadNet | $79.09 | $69.00 | -12.76% | Buy |
| OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |